Previous close | 480.50 |
Open | 482.01 |
Bid | 0.00 x 800 |
Ask | 0.00 x 800 |
Day's range | 478.01 - 489.37 |
52-week range | 317.06 - 560.92 |
Volume | |
Avg. volume | 487,030 |
Market cap | 40.017B |
Beta (5Y monthly) | 1.14 |
PE ratio (TTM) | 61.48 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announces new reference laboratory tests and services to help veterinarians gain insights during wellness screenings, develop treatment plans for cats with chronic kidney disease, and access fast, definitive answers for the most critical cases.